pre-update Archives

Blog

A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease

New therapeutics discovery and development for ocular diseases have been traditionally associated with a low…

CertaraDecember 15, 2021

Press Release

Certara Announces Release of Pinnacle 21 Enterprise Software

New metrics and analytics capabilities enable informed decision making for biopharmaceutical clients PRINCETON, N.J., Dec.…

CertaraDecember 13, 2021

Press Coverage

Discovery Data – New Architecture Needed to Support New Modalities

CertaraDecember 2, 2021

On-Demand Webinar

Predicting and Taming Immunogenicity: Strategies for your Biologic Drug

Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…

CertaraNovember 19, 2021

Press Coverage

Accelerating the establishment of precision medicine using PK-PD/TD modeling

Certara’s Japan team first met Dr. Kobuchi when he was studying Pharmacometrics at university for…

CertaraNovember 18, 2021

Press Coverage

Leveraging real-world data to meet payers’ needs

CertaraNovember 15, 2021

Press Coverage

Drug Discovery World: The Value of Scientific Intelligence in Drug Discovery

CertaraNovember 9, 2021

Announcement

Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training

PRINCETON, N.J.— November 8, 2021 -- Certara, Inc, a global leader in biosimulation, today announced…

CertaraNovember 8, 2021

Blog

Developing Targeted Covalent Inhibitor Drugs: 3 Key Considerations

Traditional mechanisms of drug action rely on the reversible, noncovalent interaction of a ligand with…

CertaraNovember 5, 2021

White Paper

The Importance of Collecting Race/Ethnicity Information in Clinical Trials for Biologics – A Clinical Pharmacology Perspective

CertaraNovember 2, 2021

pre-update

A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease

Certara Announces Release of Pinnacle 21 Enterprise Software

Discovery Data – New Architecture Needed to Support New Modalities

Predicting and Taming Immunogenicity: Strategies for your Biologic Drug

Accelerating the establishment of precision medicine using PK-PD/TD modeling

Leveraging real-world data to meet payers’ needs

Drug Discovery World: The Value of Scientific Intelligence in Drug Discovery

Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training

Developing Targeted Covalent Inhibitor Drugs: 3 Key Considerations

The Importance of Collecting Race/Ethnicity Information in Clinical Trials for Biologics – A Clinical Pharmacology Perspective

Newsletter sign up

Quick links

Solutions

Contact